Search Results
Search for other papers by Pedro Weslley Rosario in
Google Scholar
PubMed
Search for other papers by Tiara Grossi Rocha in
Google Scholar
PubMed
Search for other papers by Gabriela Franco Mourão in
Google Scholar
PubMed
et al. 2014 ), and TIR3 of the Italian Reporting System ( Pacini et al. 2018 ) are defined as ‘indeterminate’ cytology ( Table 1 ). This result corresponds to approximately 10–25% of all FNAs ( Gharib et al. 2016 , Pacini et al. 2018
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Search for other papers by Marina Muzza in
Google Scholar
PubMed
Search for other papers by Gabriele Pogliaghi in
Google Scholar
PubMed
Search for other papers by Sonia Palazzo in
Google Scholar
PubMed
Search for other papers by Guia Vannucchi in
Google Scholar
PubMed
Search for other papers by Leonardo Vicentini in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Search for other papers by Giacomo Gazzano in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
and histological data, and risk score of the 65 patients with indeterminate cytology submitted to surgery. Molecular data were obtained by means of the PTC-MA assay ( Nikiforova et al . 2018 , Colombo et al . 2019 ). Patient ID Gender
Search for other papers by Pedro Weslley Rosario in
Google Scholar
PubMed
Dear Editor, We thank Qichang and Bin for the comments regarding our review ‘Usefulness of accessible imaging methods in thyroid nodules with indeterminate cytology’ ( Rosário et al . 2021 ), published in this issue of Endocrine
Search for other papers by Pablo Valderrabano in
Google Scholar
PubMed
Search for other papers by Laila Khazai in
Google Scholar
PubMed
Search for other papers by Marino E Leon in
Google Scholar
PubMed
Search for other papers by Zachary J Thompson in
Google Scholar
PubMed
Search for other papers by Zhenjun Ma in
Google Scholar
PubMed
Search for other papers by Christine H Chung in
Google Scholar
PubMed
Search for other papers by Julie E Hallanger-Johnson in
Google Scholar
PubMed
Search for other papers by Kristen J Otto in
Google Scholar
PubMed
Search for other papers by Kara D Rogers in
Google Scholar
PubMed
Search for other papers by Barbara A Centeno in
Google Scholar
PubMed
Search for other papers by Bryan McIver in
Google Scholar
PubMed
Introduction Several molecular marker tests are available to refine the diagnosis of thyroid nodules with indeterminate cytology. Initially, these tests were classified as either ‘rule-in’ or ‘rule-out’ tests, depending on their ability to
Search for other papers by Qi-Chang Wan in
Google Scholar
PubMed
Search for other papers by Bin Ji in
Google Scholar
PubMed
of thyroid nodules with indeterminate cytology (TNIC) ( Rosario et al. 2021 ). For 18 F-FDG-PET, it was stated that ‘a nodule characterized by low or absent 18 F-FDG uptake is considered at a very low risk of malignance’, and ‘thyroidectomy can be
Search for other papers by Tanner Freeman in
Google Scholar
PubMed
Search for other papers by Charit Taneja in
Google Scholar
PubMed
Search for other papers by N Paul Ohori in
Google Scholar
PubMed
Search for other papers by Abigail I Wald in
Google Scholar
PubMed
Search for other papers by John Skaugen in
Google Scholar
PubMed
Search for other papers by Linwah Yip in
Google Scholar
PubMed
Search for other papers by Seungwon Kim in
Google Scholar
PubMed
UPMC Hillman Cancer Center, Department of Oncology, Pittsburgh, Pennsylvania, USA
Search for other papers by Robert L Ferris in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Search for other papers by Somak Roy in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
2018 ). This association raises the possibility of utilizing molecular markers to detect RCC metastatic to distant sites. ThyroSeq ® version 3 (v3), a targeted next-generation sequencing (NGS) test used for thyroid nodules with indeterminate cytology
Search for other papers by Pedro Weslley Rosario in
Google Scholar
PubMed
Search for other papers by Gabriela Franco Mourão in
Google Scholar
PubMed
Search for other papers by Maurício Buzelin Nunes in
Google Scholar
PubMed
Search for other papers by Marcelo Saldanha Nunes in
Google Scholar
PubMed
Search for other papers by Maria Regina Calsolari in
Google Scholar
PubMed
et al . 2016 ) was common in NIFTP, while a highly suspicious appearance was rarely observed ( Table 1 ). NIFTP more frequently exhibited indeterminate cytology (Bethesda categories iii or iv) (62%), while malignant cytology was uncommon (4%) ( Table
Search for other papers by Sergio Vargas-Salas in
Google Scholar
PubMed
Search for other papers by José R Martínez in
Google Scholar
PubMed
Search for other papers by Soledad Urra in
Google Scholar
PubMed
Search for other papers by José Miguel Domínguez in
Google Scholar
PubMed
Search for other papers by Natalia Mena in
Google Scholar
PubMed
Search for other papers by Thomas Uslar in
Google Scholar
PubMed
Search for other papers by Marcela Lagos in
Google Scholar
PubMed
Search for other papers by Marcela Henríquez in
Google Scholar
PubMed
Search for other papers by Hernán E González in
Google Scholar
PubMed
ZW Cibas ES Chudova D Diggans J Friedman L Kloos RT LiVolsi VA Mandel SJ , 2012 Preoperative diagnosis of benign thyroid nodules with indeterminate cytology . New England Journal of Medicine 367 705 – 715 . ( https://doi.org/10.1056/NEJMoa
Search for other papers by Arivarasan Karunamurthy in
Google Scholar
PubMed
Search for other papers by Federica Panebianco in
Google Scholar
PubMed
Search for other papers by Susan J Hsiao in
Google Scholar
PubMed
Search for other papers by Jennie Vorhauer in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Search for other papers by Simion Chiosea in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
samples is placed in indeterminate cytological category, preventing optimal patient management (Haugen et al. 2016). Advances in sequencing technology coupled with better understanding of the molecular mechanisms of thyroid tumorigenesis have led to
Search for other papers by Alyaksandr V Nikitski in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Search for other papers by Linwah Yip in
Google Scholar
PubMed
Search for other papers by Esra Karslioglu-French in
Google Scholar
PubMed
Search for other papers by Sally E Carty in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
routinely on FNA samples with indeterminate cytology and on selected surgical pathology samples as part of clinical care. Available de-identified demographic, clinical, and pathologic data were extracted from the database. Molecular analysis ThyroSeq